Journal: Cell Death & Disease
Article Title: Repurposing MDM2 inhibitor RG7388 for TP53 -mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axis
doi: 10.1038/s41419-025-07770-2
Figure Lengend Snippet: A , B Detection of ROS by immunofluorescence of HCC827 ( A ) or H23 ( B ) cells stably transfected with non-targeting sgRNA or sgRNA-NOXA. ROS staining (green) and mitochondrial staining (red) are shown. C – E Gene ontology (GO) enrichment analysis using differentially expressed genes showed strong clustering of transcription factor AP-1 complex genes ( JUND, JUNB, JUN and FOS ) which were altered in RG7388 treated cells compared with control cells in HCC827 and PC9 cells. F – K Immunoblot analysis of p-p38, p-JNK, NOXA and β-actin expression in HCC827 or PC9 cells pre-treated with total ROS inhibitor NAC ( F ) or lipid ROS inhibitor Fer-1 ( I ) at the indicated concentration for 1 hour and then treated with 60 μM RG7388 for 6 hours. The protein expression levels of p-p38, p-JNK, and NOXA in HCC827 ( G , J ) or PC9 ( H , K ) were semi-quantitatively assessed using ImageJ software. Quantitative data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. L Immunoblot analysis of p-JNK, NOXA and β-actin expression in HCC827, PC9 or H23 cells pre-treated with 40 μM JNK inhibitor SP600125 for 1 hour and then treated with 60 μM RG7388 for 6 hours. M Immunoblot analysis of p-p38, NOXA and β-actin expression in HCC827 or H1975 cells treated with p38 inhibitor SB203580 (40 μM) for 6 h. N – P Immunoblot analysis of p-p38, NOXA and β-actin expression in HCC827 or PC9 cells pre-treated with 40 μM SB203580 for 1 hour and then treated with 60 μM RG7388 for 6 h. The protein expression levels of p-p38 and NOXA in HCC827 ( O ) or PC9 ( P ) were semi-quantitatively assessed using ImageJ software. Quantitative data are presented as mean ± SD. *** p < 0.001. Q Representative IF images of NOXA intensity (Red) and nucleus stained with DAPI (blue) in HCC827 cells pre-treated with 40 μM SP600125 or SB203580 for 1 hour and then treated with 60 μM RG7388 for 6 h.
Article Snippet: RG7388 (T6254), SB203580 (T1764) and Ferrostatin-1 (T6500) were obtained from Target Mol (Boston, USA).
Techniques: Immunofluorescence, Stable Transfection, Transfection, Staining, Control, Western Blot, Expressing, Concentration Assay, Software